Insider · CIK 0001942597
Stuart Poulton
Files at KPTI (Karyopharm Therapeutics Inc.). First filing Feb 19, 2025, latest Mar 3, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KPTI: Karyopharm Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | Karyopharm Therapeutics Inc. | $48k 5,101 shares | -5% | +171% from low-5% from high | |
| 30Weak | Karyopharm Therapeutics Inc. | $3,262 378 shares | -0% | +166% from low-4% from high | |
| 30Weak | Karyopharm Therapeutics Inc. | $2,578 401 shares | -1% | +77% from low-58% from high | |
| 23Weak | Karyopharm Therapeutics Inc. | $835 191 shares | -1% | +17% from low-72% from high | |
| 35Weak | Karyopharm Therapeutics Inc. | $22k 3,548 shares | -11% | - | |
| 30Weak | Karyopharm Therapeutics Inc. | $3,726 5,914 shares | -2% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -5,101 | $9.41 | $48k | 94,328 | Mar 3, 2026 |
| Feb 17, 2026 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -378 | $8.63 | $3,262 | 99,429 | Feb 19, 2026 |
| Jan 31, 2026 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +32,415 | $0.00 | $0 | 99,807 | Feb 3, 2026 |
| Oct 15, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +39,682 | $0.00 | $0 | 67,392 | Oct 16, 2025 |
| Sep 12, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +888 | $0.00 | $0 | 28,111 | Sep 16, 2025 |
| Sep 15, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -401 | $6.43 | $2,578 | 27,710 | Sep 16, 2025 |
| Jul 29, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -191 | $4.37 | $835 | 27,223 | Jul 30, 2025 |
| Mar 4, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -3,548 | $6.29 | $22k | 27,414 | Mar 6, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 26,379 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Common Stock | +4,583 | $0.00 | $0 | 30,962 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Mar 4, 2025 |
| Feb 28, 2025 | KPTI Karyopharm Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +9,166 | $0.00 | $0 | 9,166 | Mar 4, 2025 |
| Feb 18, 2025 | KPTI Karyopharm Therapeutics Inc. | SOpen-market sale Common Stock | -5,914 | $0.63 | $3,726 | 320,714 | Feb 19, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.